secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2024-08-14T23:59:59+00:00
Accession:  0001493152-24-032169
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TNF Pharmaceuticals amends Series G Preferred Stock dividend calculation method
-------------------------------------------------------------------------------

- Amendment changes how in-kind dividends (additional Preferred Stock shares) are determined.
- Certificate of Amendment filed with Delaware Secretary of State on August 8, 2024.
- Amendment approved by Required Holders (majority of outstanding Preferred Stock).
- Other terms of Series G Preferred Stock and related documents remain unchanged.
- Event modifies rights of security holders under Item 3.03.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224032169/0001493152-24-032169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315224032169/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-032169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer